Publication Cover
Caryologia
International Journal of Cytology, Cytosystematics and Cytogenetics
Volume 63, 2010 - Issue 4
420
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

The Genotoxic and Antimitotic Properties of Helichrysum plicatum Herbal Teas Widely Consumed in Turkey

, , &
Pages 376-381 | Received 18 Feb 2010, Accepted 30 Nov 2010, Published online: 04 Feb 2014
 

Abstract

Helichrysum plicatum DC. subsp. plicatum (Asteraceae), (common name; everlasting) is a medicinal plant and natural product. For centuries, it has been used as tea in Turkey because of its medicinal properties. There are few reports in literature about genotoxic effects of this plant. The aim of this work is to evaluate the genotoxic and antimitotic effects on human lymphocyte cultures induced by aqueous (decoction) extracts of this plant which were assayed in different concentrations (0.01, 0.05, 0.1, 0.5 and 1 mg/mL). Helichrysum plicatum subsp. plicatum extracts used in alternative medicine induced the formation of micronuclei, decreased the mitotic and replication indexes compared to untreated group (control). Indeed, it causes chromosomal damage (an increase in micronucleus) and delay in the cell division (decrease in mitotic and replication indexes). It should therefore not be used freely in high concentrations in alternative medicine although its antiproliferative activity may suggest as an antimitotic product.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.